enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
enVVeno Medical announced the issuance of U.S. Patent No. 12,575,932, covering key components of its enVVe transcatheter replacement venous valve system and associated methods for treating deep venous insufficiency. The patent protection encompasses the valve, support frame, crimping system, and delivery mechanisms, reinforcing the company's competitive position as it prepares for the TAVVE pivotal study under an FDA-approved IDE.
Key figures
- Data timeline
- End of Q4 2026
- Patent number
- 12,575,932
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.